Sulforaphane as a promising molecule for fighting cancer

Cancer Treatment and Research

Volumn 159, Issue , 2014, Pages 207-223

  Lenzi, Monia ^a   Fimognari, Carmela ^a   Hrelia, Patrizia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Angiogenesis; Isothiocyanates; Metastatic process; Phase I and II enzymes; Sulforaphane

Indexed keywords

EPOXIDE HYDROLASE; FERRITIN; GLUTAMATE CYSTEINE SYNTHETASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HEME OXYGENASE 1; SULFORAPHANE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ISOTHIOCYANIC ACID DERIVATIVE; SULFORAFAN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CYTOSTASIS; CYTOTOXICITY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; G2 PHASE CELL CYCLE CHECKPOINT; GENETIC TRANSCRIPTION; GENETICS; HEALTH PROMOTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; M PHASE CELL CYCLE CHECKPOINT; MALIGNANT NEOPLASTIC DISEASE; METASTASIS INHIBITION; MUTAGENESIS; NONHUMAN; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; S PHASE CELL CYCLE CHECKPOINT; SAFETY; ANIMAL; NEOPLASMS; NEOPLASM; REVIEW;

ANIMALS; ANTICARCINOGENIC AGENTS; HUMANS; ISOTHIOCYANATES; NEOPLASMS;

EID: 84897299629     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-38007-5_12     Document Type: Article

References (95)

1. Asakage M, Tsuno NH, Kitayama J et al (2006) Sulforaphane induces inhibition of human umbilical vein endothelial cells proliferation by apoptosis. Angiogenesis 9:83–91
2. Bacon JR, Williamson G, Garner RC et al (2003) Sulforaphane and quercetin modulate PhIPDNA adduct formation in human HepG2 cells and hepatocytes. Carcinogenesis 24:1903–1911
3. Bacon JR, Plumb GW, Howie AF et al (2007) Dual action of sulforaphane in the regulation of thioredoxin reductase and thioredoxin in human HepG2 and Caco-2 cells. J Agric Food Chem 55:1170–1176
4. Barcelo S, Gardiner JM, Gescher A et al (1996) CYP2E1-mediated mechanism of antigenotoxicity of the broccoli constituent sulforaphane. Carcinogenesis 17:277–282
5. Barcelo S, Mace K, Pfeifer AM et al (1998) Production of DNA strand breaks by Nnitrosodimethylamine and 2-amino-3-methylimidazo[4, 5-f]quinoline in THLE cells expressing human CYP isoenzymes and inhibition by sulforaphane. Mutat Res 402:111–120
6. Basten GP, Bao Y, Williamson G (2002) Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UGT1A1) and glutathione transferase (GSTA1) in cultured cells. Carcinogenesis 23:1399–1404
7. Bertl E, Bartsch H, Gerhauser C (2006) Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention. Mol Cancer Ther 5:575–585
8. Bonnesen C, Eggleston IM, Hayes JD (2001) Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res 61:6120–6130
9. Brooks JD, Paton VG, Vidanes G (2001) Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol Biomarkers Prev 10:949–954
10. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249–257
11. Chambers AF, Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89:1260–1270
12. Chaudhuri D, Orsulic S, Ashok BT (2007) Antiproliferative activity of sulforaphane in Aktoverexpressing ovarian cancer cells. Mol Cancer Ther 6:334–345
13. Chen MJ, Tang WY, Hsu CW et al (2012) Apoptosis induction in primary human colorectal cancer cell lines and retarded tumor growth in SCID mice by sulforaphane. Evid Based Complement Alternat Med 2012:415231
14. Chiao JW, Chung FL, Kancherla R et al (2002) Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int J Oncol 20:631–636
15. Choi S, Lew KL, Xiao H et al (2007) D, L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1. Carcinogenesis 28:151–162
16. Clarke JD, Hsu A, Yu Z et al (2011) Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells. Mol Nutr Food Res 55:999–1009
17. Conaway CC, Wang CX, Pittman B et al (2005) Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res 65:8548–8557
18. Cornblatt BS, Ye L, Dinkova-Kostova AT et al (2007) Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis 28:1485–1490
19. Dashwood RH (2002) Modulation of heterocyclic amine-induced mutagenicity and carcinogenicity: an ‘A-to-Z’ guide to chemopreventive agents, promoters, and transgenic models. Mutat Res 511:89–112
20. Dinkova-Kostova AT, Holtzclaw WD, Cole RN et al (2002) Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 99:11908–11913
21. Fahey JW, Haristoy X, Dolan PM et al (2002) Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci USA 99:7610–7615
22. Fidler IJ (1978) Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38:2651–2660
23. Fimognari C, Nusse M, Cesari R et al (2002) Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis 23:581–586
24. Fimognari C, Nusse M, Berti F et al (2003) Sulforaphane modulates cell cycle and apoptosis in transformed and non-transformed human T lymphocytes. Ann NY Acad Sci 1010:393–398
25. Fimognari C, Nusse M, Berti F et al (2004) Isothiocyanates as novel cytotoxic and cytostatic agents: molecular pathway on human transformed and non-transformed cells. Biochem Pharmacol 68:1133–1138
26. Fimognari C, Berti F, Cantelli-Forti G et al (2005) Effect of sulforaphane on micronucleus induction in cultured human lymphocytes by four different mutagens. Environ Mol Mutagen 46:260–267
27. Fimognari C, Sangiorgi L, Capponcelli S et al (2005) A mutated p53 status did not prevent the induction of apoptosis by sulforaphane, a promising anti-cancer drug. Invest New Drugs 23:195–203
28. Fimognari C, Nusse M, Lenzi M et al (2006) Sulforaphane increases the efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutations. Mutat Res 601:92–101
29. Fimognari C, Lenzi M, Sciuscio D et al (2007) Cell-cycle specificity of sulforaphanemediated apoptosis in Jurkat T-leukemia cells. In Vivo 21:377–380
30. Fimognari C, Lenzi M, Sciuscio D et al (2007) Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation. Ann NY Acad Sci 1095:62–69
31. Fimognari C, Lenzi M, Cantelli-Forti G et al (2008) Induction of differentiation in human promyelocytic cells by the isothiocyanate sulforaphane. In Vivo 22:317–320
32. Gamet-Payrastre L, Lumeau S, Gasc N et al (1998) Selective cytostatic and cytotoxic effects of glucosinolates hydrolysis products on human colon cancer cells in vitro. Anticancer Drugs 9:141–148
33. Gamet-Payrastre L, Li P, Lumeau S et al (2000) Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 60:1426–1433
34. Gills JJ, Jeffery EH, Matusheski NV et al (2006) Sulforaphane prevents mouse skin tumorigenesis during the stage of promotion. Cancer Lett 236:72–79
35. Gingras D, Gendron M, Boivin D et al (2004) Induction of medulloblastoma cell apoptosis by sulforaphane, a dietary anticarcinogen from Brassica vegetables. Cancer Lett 203:35–43
36. Hamsa TP, Thejass P, Kuttan G (2011) Induction of apoptosis by sulforaphane in highly metastatic B16F–10 melanoma cells. Drug Chem Toxicol 34:332–340
37. Hu C, Nikolic D, Eggler AL et al (2012) Screening for natural chemoprevention agents that modify human Keap1. Anal Biochem 421:108–114
38. Itoh K, Wakabayashi N, Katoh Y et al (2003) Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 8:379–391
39. Jackson SJ, Singletary KW (2004) Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis 25:219–227
40. Jackson SJ, Singletary KW (2004) Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization. J Nutr 134:2229–2236
41. Jackson SJ, Singletary KW, Venema RC (2007) Sulforaphane suppresses angiogenesis and disrupts endothelial mitotic progression and microtubule polymerization. Vascul Pharmacol 46:77–84
42. Jakubikova J, Sedlak J, Mithen R et al (2005) Role of PI3 K/Akt and MEK/ERK signaling pathways in sulforaphane-and erucin-induced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells. Biochem Pharmacol 69:1543–1552
43. Jakubikova J, Cervi D, Ooi M et al (2011) Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma. Haematologica 96:1170–1179
44. Jee HG, Lee KE, Kim JB et al (2011) Sulforaphane inhibits oral carcinoma cell migration and invasion in vitro. Phytother Res 25:1623–1628
45. Jeong WS, Kim IW, Hu R et al (2004) Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway. Pharm Res 21:661–670
46. Jiang ZQ, Chen C, Yang B et al (2003) Differential responses from seven mammalian cell lines to the treatments of detoxifying enzyme inducers. Life Sci 72:2243–2253
47. Jones SB, Brooks JD (2006) Modest induction of phase 2 enzyme activity in the F-344 rat prostate. BMC Cancer 6:62
48. Kalpana Deepa Priya D, Gayathri R, Sakthisekaran D (2011) Role of sulforaphane in the antiinitiating mechanism of lung carcinogenesis in vivo by modulating the metabolic activation and detoxification of benzo(a)pyrene. Biomed Pharmacother 65:9–16
49. Kaminski BM, Steinhilber D, Stein JM et al (2012) Phytochemicals resveratrol and sulforaphane as potential agents for enhancing the anti-tumor activities of conventional cancer therapies. Curr Pharm Biotechnol 13:137–146
50. Kanematsu S, Yoshizawa K, Uehara N et al (2011) Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic mice. Oncol Rep 26:603–608
51. Kang HJ, Hong YB, Kim HJ et al (2012) Bioactive food components prevent carcinogenic stress via Nrf2 activation in BRCA1 deficient breast epithelial cells. Toxicol Lett 209:154–160
52. Karmakar S, Weinberg MS, Banik NL et al (2006) Activation of multiple molecular mechanisms for apoptosis in human malignant glioblastoma T98G and U87MG cells treated with sulforaphane. Neuroscience 141:1265–1280
53. Kim MR, Zhou L, Park BH et al (2011) Induction of G/M arrest and apoptosis by sulforaphane in human osteosarcoma U2-OS cells. Mol Med Report 4:929–934
54. Kuroiwa Y, Nishikawa A, Kitamura Y et al (2006) Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters. Cancer Lett 241:275–280
55. Lee JM, Johnson JA (2004) An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol 37:139–143
56. Liotta LA, Tryggvason K, Garbisa S et al (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284:67–68
57. Liotta LA (1984) Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis award lecture. Am J Pathol 117:339–348
58. Liotta LA (1986) Tumor invasion and metastases–role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res 46:1–7
59. Maheo K, Morel F, Langouet S et al (1997) Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res 57:3649–3652
60. Matusheski NV, Jeffery EH (2001) Comparison of the bioactivity of two glucoraphanin hydrolysis products found in broccoli, sulforaphane and sulforaphane nitrile. J Agric Food Chem 49:5743–5749
61. Misiewicz I, Skupinska K, Kasprzycka-Guttman T (2003) Sulforaphane and 2-oxohexyl isothiocyanate induce cell growth arrest and apoptosis in L-1210 leukemia and ME-18 melanoma cells. Oncol Rep 10:2045–2050
62. Mithen R, Faulkner K, Magrath R et al (2003) Development of isothiocyanate-enriched broccoli, and its enhanced ability to induce phase 2 detoxification enzymes in mammalian cells. Theor Appl Genet 106:727–734
63. Morimitsu Y, Nakagawa Y, Hayashi K et al (2002) A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway. J Biol Chem 277:3456–3463
64. Munday R, Munday CM (2004) Induction of phase II detoxification enzymes in rats by plantderived isothiocyanates: comparison of allyl isothiocyanate with sulforaphane and related compounds. J Agric Food Chem 52:1867–1871
65. Myzak MC, Karplus PA, Chung FL et al (2004) A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 64:5767–5774
66. Myzak MC, Dashwood WM, Orner GA et al (2006) Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. FASEB J 20:506–508
67. Myzak MC, Hardin K, Wang R et al (2006) Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis 27:811–819
68. Nguyen T, Nioi P, Pickett CB (2009) The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284:13291–13295
69. Nicolson GL (1982) Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells. Biochim Biophys Acta 695:113–176
70. Pappa G, Lichtenberg M, Iori R et al (2006) Comparison of growth inhibition profiles and mechanisms of apoptosis induction in human colon cancer cell lines by isothiocyanates and indoles from Brassicaceae. Mutat Res 599:76–87
71. Park SY, Kim GY, Bae SJ et al (2007) Induction of apoptosis by isothiocyanate sulforaphane in human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells through activation of caspase-3. Oncol Rep 18:181–187
72. Parkin DM, Bray F, Ferlay J et al (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153–156
73. Parnaud G, Li P, Cassar G et al (2004) Mechanism of sulforaphane-induced cell cycle arrest and apoptosis in human colon cancer cells. Nutr Cancer 48:198–206
74. Pham NA, Jacobberger JW, Schimmer AD et al (2004) The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice. Mol Cancer Ther 3:1239–1248
75. Pledgie-Tracy A, Sobolewski MD, Davidson NE (2007) Sulforaphane induces cell typespecific apoptosis in human breast cancer cell lines. Mol Cancer Ther 6:1013–1021
76. Rudolf E, Cervinka M (2011) Sulforaphane induces cytotoxicity and lysosome-and mitochondria-dependent cell death in colon cancer cells with deleted p53. Toxicol In Vitro 25:1302–1309
77. Shan Y, Sun C, Zhao X et al (2006) Effect of sulforaphane on cell growth, G(0)/G(1) phase cell progression and apoptosis in human bladder cancer T24 cells. Int J Oncol 29:883–888
78. Shapiro TA, Fahey JW, Dinkova-Kostova AT et al (2006) Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase I study. Nutr Cancer 55:53–62
79. Shen G, Xu C, Chen C et al (2006) p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Cancer Chemother Pharmacol 57:317–327
80. Shishu, Kaur IP (2003) Inhibition of mutagenicity of food-derived heterocyclic amines by sulforaphane–a constituent of broccoli. Indian J Exp Biol 41:216–219
81. Singh AV, Xiao D, Lew KL et al (2004) Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis 25:83–90
82. Singh SV, Herman-Antosiewicz A, Singh AV et al (2004) Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem 279:25813–25822
83. Singh SV, Srivastava SK, Choi S et al (2005) Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J Biol Chem 280:19911–19924
84. Singletary K, MacDonald C (2000) Inhibition of benzo[a]pyrene-and 1, 6-dinitropyrene-DNA adduct formation in human mammary epithelial cells by dibenzoylmethane and sulforaphane. Cancer Lett 155:47–54
85. Stetler-Stevenson WG, Hewitt R, Corcoran M (1996) Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol 7:147–154
86. Suh N, Luyengi L, Fong HH et al (1995) Discovery of natural product chemopreventive agents utilizing HL-60 cell differentiation as a model. Anticancer Res 15:233–239
87. Surh YJ (2003) Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3:768–780
88. Svehlikova V, Wang S, Jakubikova J et al (2004) Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cells. Carcinogenesis 25:1629–1637
89. Tang L, Zhang Y (2004) Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells. J Nutr 134:2004–2010
90. Thejass P, Kuttan G (2006) Antimetastatic activity of sulforaphane. Life Sci 78:3043–3050
91. Wang L, Liu D, Ahmed T et al (2004) Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int J Oncol 24:187–192
92. Xu C, Shen G, Yuan X et al (2006) ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. Carcinogenesis 27:437–445
93. Zhang Y, Talalay P, Cho CG et al (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA 89:2399–2403
94. Zhang Y, Callaway EC (2002) High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. Biochem J 364:301–307
95. Zhong H, Bowen JP (2006) Antiangiogenesis drug design: multiple pathways targeting tumor vasculature. Curr Med Chem 13:849–862